顶部logo
顶部logo
more_1

home

ホーム > レポート一覧 > β-ニコチンアミドモノヌクレオチド(NMN)の世界市場規模、シェア、企業ランキング、売上、需要動向予測（2026～2032年）

β-ニコチンアミドモノヌクレオチド(NMN)の世界市場規模、シェア、企業ランキング、売上、需要動向予測（2026～2032年）

β-Nicotinamide Mononucleotide (NMN)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
  • レポートID：
    79842
  • 発表時期：
    2026-01-05
  • レポート形式：
    PDF
  • 産業カテゴリー：
    化学及び材料
  • レポート言語：
    英語、日本語
  • ページ数：
    98
  • 発行会社（調査会社）：
    QYResearch
title

言語とエディションの価格

  • 英語版
  • 日本語版
  • 英語と日本語版

個人版詳細

マルチユーザー版詳細

企業版詳細

  • 英語版
  • 日本語版
  • 英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.40円。

※米ドル表示価格+10％消費税。

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

title

レポートの概要

本報告書は、世界のβ-ニコチンアミドモノヌクレオチド(NMN)市場について包括的な分析を行い、市場全体の動向を明らかにすることを目的としています。総販売数量、売上高、価格動向に加え、主要企業の市場シェアおよび順位を整理し、市場構造を多角的に把握します。さらに、地域・国別、製品タイプ別、用途分野別などの観点からβ-ニコチンアミドモノヌクレオチド(NMN)市場を分析し、需要構造と成長特性を明確化します。
β-ニコチンアミドモノヌクレオチド(NMN)市場の規模、推定値および予測は、2025年を基準年とし、2021年から2032年までの期間における販売数量および売上高に基づいて提示しています。定量分析と定性分析を組み合わせることで、ビジネスおよび成長戦略を検討し、市場競争環境を評価し、企業の市場ポジションを把握した上で、β-ニコチンアミドモノヌクレオチド(NMN)に関する的確な意思決定を行うための実践的なインサイトを提供します。
 主要β-ニコチンアミドモノヌクレオチド(NMN)市場の統計
2025年世界市場規模：468百万米ドル
2026年世界市場規模：524百万米ドル
2032年予測市場規模：1112百万米ドル
2026–2032年予測期間CAGR：13.4%
本レポートはβ-ニコチンアミドモノヌクレオチド(NMN)市場の中長期的な成長動向を定量分析および定性分析の両面から体系的に整理しています。 
【市場セグメンテーション】
主要企業・競争環境
β-ニコチンアミドモノヌクレオチド(NMN)市場の主要企業には以下が含まれます：
GeneHarbor
Herbalmax
Genex Formulas
Mirailab Bioscience
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
ABA Chemical 

製品別
Content ≥98%
Content ＜98% 

アプリケーション別
Health Care Products
Cosmetics
Others 

レポート対象地域
北米：アメリカ、カナダ、その他
アジア太平洋：中国、日本、韓国、東南アジア、インド、オーストラリア、その他
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、オランダ、北欧諸国、その他
ラテンアメリカ：メキシコ、ブラジル、その他
中東・アフリカ：トルコ、サウジアラビア、UAE、その他

レポート構成（章別概要）
第1章｜市場概要と成長展望
β-ニコチンアミドモノヌクレオチド(NMN)市場の全体像を整理し、市場規模、売上予測、価格推移を体系的に解説します。同時に成長要因、市場機会、業界課題、リスク要因を分析し、中長期的な市場展望を提示します
第2章｜主要企業の競争分析
β-ニコチンアミドモノヌクレオチド(NMN)市場における主要プレイヤー（トップ5社・トップ10社）を対象に、売上高、製造拠点、製品構成、価格戦略、販売量、市場シェアを多面的に分析し、競争構造を明確化します
第3章｜製品カテゴリ別市場動向
製品タイプ別にβ-ニコチンアミドモノヌクレオチド(NMN)市場を分類し、売上高、市場シェア、販売量、価格動向を分析します。成長性の高い製品分野と市場構造の変化を明らかにします
第4章｜用途別市場動向
用途別にβ-ニコチンアミドモノヌクレオチド(NMN)市場規模、売上高、市場シェア、販売量、価格推移を整理し、業界別の需要動向と成長ポテンシャルを分析します
第5章｜地域別市場分析
地域別の市場成長率、販売量、売上高を詳細に分析し、β-ニコチンアミドモノヌクレオチド(NMN)市場の地理的需要構造を可視化します。各地域の市場規模推移と将来の成長余地を評価します
第6章｜国別市場動向
主要国・地域ごとに、β-ニコチンアミドモノヌクレオチド(NMN)市場の販売量、売上高、成長要因、政策・規制環境、競争特性を整理し、国別市場の特徴を明確にします
第7章｜主要企業プロファイル
β-ニコチンアミドモノヌクレオチド(NMN)市場を牽引する主要企業について、売上高、販売量、価格動向、粗利益率、製品ポートフォリオ、最新の戦略動向を詳細に解説します
第8章｜バリューチェーンと市場構造分析
業界全体のサプライチェーンを上流から下流まで整理し、コスト構造や流通モデルの動向を分析します
第9章｜調査結果
調査結果を総括し、市場全体のトレンド、今後の成長機会、潜在的リスク、戦略的な洞察を提示します
第10章｜付録（調査手法・データソース）
調査設計、分析手法、使用データソースの詳細を明示し、レポートの信頼性と透明性を担保します

本レポートの要点と洞察
●β-ニコチンアミドモノヌクレオチド(NMN)市場の全体像と成長見通し
β-ニコチンアミドモノヌクレオチド(NMN)市場の規模変化の傾向、成長予測及び需要動向を体系的に整理いたします。2021年から2025年までの実績データに基づき、2032年までの中長期予測を提示し、市場の拡大速度と成長潜在力を明らかにします。同時に、最近の関税調整措置など各国の政策動向を踏まえ、多角的にグローバル経済環境がβ-ニコチンアミドモノヌクレオチド(NMN)市場に与える影響を分析いたします。
●市場環境の構成要素とマクロトレンド
β-ニコチンアミドモノヌクレオチド(NMN)産業を取り巻く市場環境について、需要構造の変化、政策対応、技術革新の進展といった主要要因を整理します。特に、国際貿易政策や関税政策の変化が企業戦略や価格形成に及ぼす影響、サプライチェーン再編の動きと事業運営への波及効果を明確化し、市場環境の全体像を包括的に提示します。
●競争構造と主要企業の動向分析
β-ニコチンアミドモノヌクレオチド(NMN)市場における主要企業の売上規模、市場シェア、競争ポジションを整理し、競争構造の特徴を分析します。各社の競争戦略、事業拡大の方向性、新製品・新技術の投入動向を通じて、技術革新が市場競争に与える影響と競争環境の変化を解読します。
●競争環境と事業動向の把握
製品タイプ別、用途別、地域・国別の観点からβ-ニコチンアミドモノヌクレオチド(NMN)市場のセグメント構造を整理します。各地域の需要構成と成長特性を比較分析し、各細分領域が市場全体の成長に与える貢献度と相互関連性を明確にします。
●成長要因・課題・リスクの分析
β-ニコチンアミドモノヌクレオチド(NMN)市場の成長を支える主要ドライバーを整理するとともに、業界特有の課題や潜在的リスクを分析します。原材料調達、供給システム、事業運営における不確実性を踏まえ、サプライチェーン及び事業レジリエンス強化の方向性についても考察します。
●将来トレンドと市場展望
β-ニコチンアミドモノヌクレオチド(NMN)市場の中長期的な成長トレンドと将来の発展シナリオを提示します。持続的成長を実現するための重要な成功要因を整理し、今後の市場参入企業や既存プレイヤーの戦略的意思決定に参考となる視点を提供いたします。
title

Description

The global market for β-Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 468 million in 2025 and is projected to reach US$ 1112 million, growing at a CAGR of 13.4% from 2026 to 2032.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on β-Nicotinamide Mononucleotide (NMN) cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.

NMN is a precursor of nicotinamide adenine dinucleotide (NAD+), which plays a vital role in cell metabolism and energy production. As we age, the level of NAD+ in the human body gradually decreases, resulting in weakened cell metabolism, which in turn triggers a series of aging-related diseases. Therefore, increasing the level of NAD+ in the body by supplementing NMN has become a new way to fight aging and maintain good health.

With the general improvement of global health awareness and continuous breakthroughs in scientific research and technology, the growth momentum of the NMN market will continue to increase. In the future, the NMN market will achieve a deeper cross-border integration with other health industries such as biotechnology, precision medicine, and nutritional supplements, giving rise to a series of innovative products and service models to meet consumers' more personalized and precise health needs.

At present, nicotinamide mononucleotide (NMN) is still in the development stage. There are not many manufacturers in the global market, and consumers have weak awareness of its use, especially in developing countries. The demand is lower than that in developed countries around the world, but the demand in developing countries is growing rapidly. Leading giants have proposed expansion plans and increased production bases.

Nicotinamide mononucleotide (NMN) core manufacturers include GeneHarbor, Mirailab Bioscience, Maac10 Formulas, Herbalmax and Genex Formula. China is the largest production area, accounting for about 84% of the global market share, followed by North America and Japan. The downstream applications of nicotinamide mononucleotide include health products, cosmetics, etc. Globally, health products are the largest application market, and raw materials for health products account for 99% of the total sales of nicotinamide mononucleotide in 2023.

This report provides a comprehensive view of the global market for β-Nicotinamide Mononucleotide (NMN), covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The β-Nicotinamide Mononucleotide (NMN) market size, estimations, and forecasts are presented in terms of sales volume (Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding β-Nicotinamide Mononucleotide (NMN).

Market Segmentation
By Company
    GeneHarbor
    Herbalmax
    Genex Formulas
    Mirailab Bioscience
    Maac10 Formulas
    EffePharm
    Bontac
    CELFULL
    Kingdomway
    ABA Chemical

Segment by Type
    Content ≥98%
    Content ＜98%

Segment by Application
    Health Care Products
    Cosmetics
    Others

By Region
    North America
    China
    Japan

Consumption by Region
    North America
        United States
        Canada
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia-Pacific
    Europe
        Germany
        France
        U.K.
        Italy
        Netherlands
        Nordic Countries
        Rest of Europe
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the β-Nicotinamide Mononucleotide (NMN) manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents β-Nicotinamide Mononucleotide (NMN) sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents β-Nicotinamide Mononucleotide (NMN) sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
title

Table of Contents

1 Market Overview
    1.1 β-Nicotinamide Mononucleotide (NMN) Product Introduction
    1.2 Global β-Nicotinamide Mononucleotide (NMN) Market Size Forecast
        1.2.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Value (2021–2032)
        1.2.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume (2021–2032)
        1.2.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Price (2021–2032)
    1.3 β-Nicotinamide Mononucleotide (NMN) Market Trends & Drivers
        1.3.1 β-Nicotinamide Mononucleotide (NMN) Industry Trends
        1.3.2 β-Nicotinamide Mononucleotide (NMN) Market Drivers & Opportunities
        1.3.3 β-Nicotinamide Mononucleotide (NMN) Market Challenges
        1.3.4 β-Nicotinamide Mononucleotide (NMN) Market Restraints
        1.3.5 Impact of U.S. Tariffs
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered
2 Competitive Analysis by Company
    2.1 Global β-Nicotinamide Mononucleotide (NMN) Players Revenue Ranking (2025)
    2.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Company (2021–2026)
    2.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume Ranking of Players (2025)
    2.4 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Company (2021–2026)
    2.5 Global β-Nicotinamide Mononucleotide (NMN) Average Price by Company (2021–2026)
    2.6 Key Manufacturers β-Nicotinamide Mononucleotide (NMN) Manufacturing Base and Headquarters
    2.7 Key Manufacturers β-Nicotinamide Mononucleotide (NMN) Product Offerings
    2.8 Key Manufacturers Start of Mass Production of β-Nicotinamide Mononucleotide (NMN)
    2.9 β-Nicotinamide Mononucleotide (NMN) Market Competitive Analysis
        2.9.1 β-Nicotinamide Mononucleotide (NMN) Market Concentration Rate (2021–2026)
        2.9.2 Global 5 and 10 Largest Manufacturers by β-Nicotinamide Mononucleotide (NMN) Revenue in 2025
        2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on β-Nicotinamide Mononucleotide (NMN) revenue, 2025
    2.10 Mergers & Acquisitions and Expansion
3 Segmentation β-Nicotinamide Mononucleotide (NMN) Market Classification
    3.1 Introduction by Type
        3.1.1 Content ≥98%
        3.1.2 Content ＜98%
        3.1.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Type
            3.1.3.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (2021 vs 2025 vs 2032)
            3.1.3.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Value, by Type (2021–2032)
            3.1.3.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Value, by Type (%), 2021–2032
        3.1.4 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Type
            3.1.4.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Type (2021 vs 2025 vs 2032)
            3.1.4.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume, by Type (2021–2032)
            3.1.4.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume, by Type (%), 2021–2032
        3.1.5 Global β-Nicotinamide Mononucleotide (NMN) Average Price by Type (2021–2032)
4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Health Care Products
        4.1.2 Cosmetics
        4.1.3 Others
    4.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Application
        4.2.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Application (2021 vs 2025 vs 2032)
        4.2.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Value, by Application (2021–2032)
        4.2.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Value, by Application (%), 2021–2032
    4.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Application
        4.3.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Application (2021 vs 2025 vs 2032)
        4.3.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume, by Application (2021–2032)
        4.3.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume, by Application (%), 2021–2032
    4.4 Global β-Nicotinamide Mononucleotide (NMN) Average Price by Application (2021–2032)
5 Segmentation by Region
    5.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Region
        5.1.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Region: 2021 vs 2025 vs 2032
        5.1.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Region (2021–2026)
        5.1.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Region (2027–2032)
        5.1.4 Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Region (%), 2021–2032
    5.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Region
        5.2.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Region: 2021 vs 2025 vs 2032
        5.2.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Region (2021–2026)
        5.2.3 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Region (2027–2032)
        5.2.4 Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Region (%), 2021–2032
    5.3 Global β-Nicotinamide Mononucleotide (NMN) Average Price by Region (2021–2032)
    5.4 North America
        5.4.1 North America β-Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032
        5.4.2 North America β-Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2025 vs 2032
    5.5 Europe
        5.5.1 Europe β-Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032
        5.5.2 Europe β-Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2025 vs 2032
    5.6 Asia Pacific
        5.6.1 Asia Pacific β-Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032
        5.6.2 Asia Pacific β-Nicotinamide Mononucleotide (NMN) Sales Value by Region (%), 2025 vs 2032
    5.7 South America
        5.7.1 South America β-Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032
        5.7.2 South America β-Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2025 vs 2032
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032
        5.8.2 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions β-Nicotinamide Mononucleotide (NMN) Sales Value Growth Trends, 2021 vs 2025 vs 2032
    6.2 Key Countries/Regions β-Nicotinamide Mononucleotide (NMN) Sales Value and Sales Volume
        6.2.1 Key Countries/Regions β-Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032
        6.2.2 Key Countries/Regions β-Nicotinamide Mononucleotide (NMN) Sales Volume, 2021–2032
    6.3 United States
        6.3.1 United States β-Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032
        6.3.2 United States β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032
        6.3.3 United States β-Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2025 vs 2032
    6.4 Europe
        6.4.1 Europe β-Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032
        6.4.2 Europe β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032
        6.4.3 Europe β-Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2025 vs 2032
    6.5 China
        6.5.1 China β-Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032
        6.5.2 China β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032
        6.5.3 China β-Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2025 vs 2032
    6.6 Japan
        6.6.1 Japan β-Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032
        6.6.2 Japan β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032
        6.6.3 Japan β-Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2025 vs 2032
    6.7 South Korea
        6.7.1 South Korea β-Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032
        6.7.2 South Korea β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032
        6.7.3 South Korea β-Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2025 vs 2032
    6.8 Southeast Asia
        6.8.1 Southeast Asia β-Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032
        6.8.2 Southeast Asia β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032
        6.8.3 Southeast Asia β-Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2025 vs 2032
    6.9 India
        6.9.1 India β-Nicotinamide Mononucleotide (NMN) Sales Value, 2021–2032
        6.9.2 India β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032
        6.9.3 India β-Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2025 vs 2032
7 Company Profiles
    7.1 GeneHarbor
        7.1.1 GeneHarbor Company Information
        7.1.2 GeneHarbor Introduction and Business Overview
        7.1.3 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021–2026)
        7.1.4 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product Offerings
        7.1.5 GeneHarbor Recent Developments
    7.2 Herbalmax
        7.2.1 Herbalmax Company Information
        7.2.2 Herbalmax Introduction and Business Overview
        7.2.3 Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021–2026)
        7.2.4 Herbalmax β-Nicotinamide Mononucleotide (NMN) Product Offerings
        7.2.5 Herbalmax Recent Developments
    7.3 Genex Formulas
        7.3.1 Genex Formulas Company Information
        7.3.2 Genex Formulas Introduction and Business Overview
        7.3.3 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021–2026)
        7.3.4 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product Offerings
        7.3.5 Genex Formulas Recent Developments
    7.4 Mirailab Bioscience
        7.4.1 Mirailab Bioscience Company Information
        7.4.2 Mirailab Bioscience Introduction and Business Overview
        7.4.3 Mirailab Bioscience β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021–2026)
        7.4.4 Mirailab Bioscience β-Nicotinamide Mononucleotide (NMN) Product Offerings
        7.4.5 Mirailab Bioscience Recent Developments
    7.5 Maac10 Formulas
        7.5.1 Maac10 Formulas Company Information
        7.5.2 Maac10 Formulas Introduction and Business Overview
        7.5.3 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021–2026)
        7.5.4 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product Offerings
        7.5.5 Maac10 Formulas Recent Developments
    7.6 EffePharm
        7.6.1 EffePharm Company Information
        7.6.2 EffePharm Introduction and Business Overview
        7.6.3 EffePharm β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021–2026)
        7.6.4 EffePharm β-Nicotinamide Mononucleotide (NMN) Product Offerings
        7.6.5 EffePharm Recent Developments
    7.7 Bontac
        7.7.1 Bontac Company Information
        7.7.2 Bontac Introduction and Business Overview
        7.7.3 Bontac β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021–2026)
        7.7.4 Bontac β-Nicotinamide Mononucleotide (NMN) Product Offerings
        7.7.5 Bontac Recent Developments
    7.8 CELFULL
        7.8.1 CELFULL Company Information
        7.8.2 CELFULL Introduction and Business Overview
        7.8.3 CELFULL β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021–2026)
        7.8.4 CELFULL β-Nicotinamide Mononucleotide (NMN) Product Offerings
        7.8.5 CELFULL Recent Developments
    7.9 Kingdomway
        7.9.1 Kingdomway Company Information
        7.9.2 Kingdomway Introduction and Business Overview
        7.9.3 Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021–2026)
        7.9.4 Kingdomway β-Nicotinamide Mononucleotide (NMN) Product Offerings
        7.9.5 Kingdomway Recent Developments
    7.10 ABA Chemical
        7.10.1 ABA Chemical Company Information
        7.10.2 ABA Chemical Introduction and Business Overview
        7.10.3 ABA Chemical β-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021–2026)
        7.10.4 ABA Chemical β-Nicotinamide Mononucleotide (NMN) Product Offerings
        7.10.5 ABA Chemical Recent Developments
8 Industry Chain Analysis
    8.1 β-Nicotinamide Mononucleotide (NMN) Industrial Chain
    8.2 β-Nicotinamide Mononucleotide (NMN) Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Key Suppliers of Raw Materials
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customer Analysis)
    8.5 Sales Model and Sales Channelss
        8.5.1 β-Nicotinamide Mononucleotide (NMN) Sales Model
        8.5.2 Sales Channels
        8.5.3 β-Nicotinamide Mononucleotide (NMN) Distributors
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer
title

Table of Figures

List of Tables
 Table 1. β-Nicotinamide Mononucleotide (NMN) Market Trends
 Table 2. β-Nicotinamide Mononucleotide (NMN) Market Drivers & Opportunities
 Table 3. β-Nicotinamide Mononucleotide (NMN) Market Challenges
 Table 4. β-Nicotinamide Mononucleotide (NMN) Market Restraints


List of Figures
 Figure 1. β-Nicotinamide Mononucleotide (NMN) Product Picture
 Figure 2. Global β-Nicotinamide Mononucleotide (NMN) Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 3. Global β-Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032
 Figure 4. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume (Tons), 2021–2032
 Figure 5. Global β-Nicotinamide Mononucleotide (NMN) Sales Price (US$/Kg), 2021–2032
 Figure 6. β-Nicotinamide Mononucleotide (NMN) Report Years Considered
 Figure 7. Global β-Nicotinamide Mononucleotide (NMN) Players Revenue Ranking (US$ Million), 2025
 Figure 8. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume Ranking of Players (Tons), 2025
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by β-Nicotinamide Mononucleotide (NMN) Revenue in 2025
 Figure 10. β-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 11. Content ≥98% Picture
 Figure 12. Content ＜98% Picture
 Figure 13. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global β-Nicotinamide Mononucleotide (NMN) Sales Value Market Share by Type, 2025 & 2032
 Figure 15. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Type (Tons), 2021 vs 2025 vs 2032
 Figure 16. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume Market Share by Type, 2025 & 2032
 Figure 17. Global β-Nicotinamide Mononucleotide (NMN) Price by Type (US$/Kg), 2021–2032
 Figure 18. Product Picture of Health Care Products
 Figure 19. Product Picture of Cosmetics
 Figure 20. Product Picture of Others
 Figure 21. Global β-Nicotinamide Mononucleotide (NMN) Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
 Figure 22. Global β-Nicotinamide Mononucleotide (NMN) Sales Value Market Share by Application, 2025 & 2032
 Figure 23. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume by Application (Tons), 2021 vs 2025 vs 2032
 Figure 24. Global β-Nicotinamide Mononucleotide (NMN) Sales Volume Market Share by Application, 2025 & 2032
 Figure 25. Global β-Nicotinamide Mononucleotide (NMN) Price by Application (US$/Kg), 2021–2032
 Figure 26. North America β-Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032
 Figure 27. North America β-Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2025 vs 2032
 Figure 28. Europe β-Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032
 Figure 29. Europe β-Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2025 vs 2032
 Figure 30. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032
 Figure 31. Asia Pacific β-Nicotinamide Mononucleotide (NMN) Sales Value by Region (%), 2025 vs 2032
 Figure 32. South America β-Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032
 Figure 33. South America β-Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2025 vs 2032
 Figure 34. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032
 Figure 35. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2025 vs 2032
 Figure 36. Key Countries/Regions β-Nicotinamide Mononucleotide (NMN) Sales Value (%), 2021–2032
 Figure 37. Key Countries/Regions β-Nicotinamide Mononucleotide (NMN) Sales Volume (%), 2021–2032
 Figure 38. United States β-Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032
 Figure 39. United States β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032
 Figure 40. United States β-Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2025 vs 2032
 Figure 41. Europe β-Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032
 Figure 42. Europe β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032
 Figure 43. Europe β-Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2025 vs 2032
 Figure 44. China β-Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032
 Figure 45. China β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032
 Figure 46. China β-Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2025 vs 2032
 Figure 47. Japan β-Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032
 Figure 48. Japan β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032
 Figure 49. Japan β-Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2025 vs 2032
 Figure 50. South Korea β-Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032
 Figure 51. South Korea β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032
 Figure 52. South Korea β-Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2025 vs 2032
 Figure 53. Southeast Asia β-Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032
 Figure 54. Southeast Asia β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032
 Figure 55. Southeast Asia β-Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2025 vs 2032
 Figure 56. India β-Nicotinamide Mononucleotide (NMN) Sales Value (US$ Million), 2021–2032
 Figure 57. India β-Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2025 vs 2032
 Figure 58. India β-Nicotinamide Mononucleotide (NMN) Sales Value by Application (%), 2025 vs 2032
 Figure 59. β-Nicotinamide Mononucleotide (NMN) Industrial Chain
 Figure 60. β-Nicotinamide Mononucleotide (NMN) Manufacturing Cost Structure
 Figure 61. Channels of Distribution (Direct Sales, and Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed

お見積>

サンプルお申込み>

今すぐ購入>

PDFダウンロード>

当社から購入のメリット
  • jiantou

    多言語（英語、日本語）のサンプル提供

  • jiantou

    プロフェッショナルな日本語翻訳を提供

  • jiantou

    請求書、クレジットカードでのお支払いが可能です

  • jiantou

    必要なチャプターやカスタマイズされたレポートの注文が可能

  • jiantou

    購入後、アナリストに直接連絡することができます

購入方法
shunxu

  • 必要な言語とバージョンのレポート選択

  • レポート要件と見積もり依頼

  • 電子メールによる注文

  • レポートの入手（英語版は2～4営業日、日本語版は8～10営業日）

  • クレジットカード決済、オフライン振込に対応（後払い可）

※当サイトに掲載されていない海外調査報告書も当社経由でご購入いただけますので、お問い合わせください。

※市場調査レポートの購入や市場調査をご希望の場合は、実績と信頼のある株式会社市場調査センターにお任せください。

*フォーチュン500企業は当社と緊密な協力関係を確立しています

クライアント様（例）
ご利用ガイド
利用規約よくあるご質問プライバシーポリシー支払い方法と購入ガイド
お電話でのお問い合わせ
email050-5840-2692 日本
email0081-50-5840-2692 グローバル
9:00-18:00 (土日・祝日を除く)
底部logo
Copyright 2016-2026 Global Reports著作権所有